Stirling products to test growth promotors in sheep.
Wednesday, 30 June, 2004
Perth-based Stirling Products (ASX:STI) is preparing for the first animal trials of its ST810 growth promotion agent in sheep.
This trial will test the affect of ST810's -- a beta-2 agonist -- on tissue weight gain and carcass quality. In published scientific literature beta-agonists have been reported to increase lean meat in sheep from 15 to 35 per cent and reduce carcass fat from 25 to 45 per cent.
Because it is a pure 'single enantiomer' molecule, rather than a mix of right and left-handed enantiomers, STA-810 stimulates only beta-2 receptors. Current growth promotant products are both beta-1 and beta-2 agonists. Selectively stimulating beta-2 receptors may mean decreased side-effects, as beta-1 agonists are associated with increased heart rate.
The trial is scheduled to commence in early spring following trial protocol and animal ethics submissions.
Shares in Stirling were up 5 per cent to AUD$0.205.
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
